Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
Recruiting · NCT06497465 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis | Recruiting | Phase 3 | 2026-09-11 | NCT06497465 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Johns Hopkins University | 579 |
| ViiV Healthcare | 53 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CePClin - Center for Studies and Research in Infectious Diseases Ltda | Natal | Brazil | 1 |
| FIOCruz | Rio de Janeiro | Brazil | 1 |
| Hospital Geral de Nova Iguaçu | Rio de Janeiro | Brazil | 1 |
| Instituto Tropical de Doenças Infecciosas Manaus | Manaus | Brazil | 1 |
| Universidade Federal da Bahia | Salvador | Brazil | 1 |